{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T13:00:37Z","timestamp":1780318837315,"version":"3.54.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.cca.2020.06.005","type":"journal-article","created":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T02:00:21Z","timestamp":1591236021000},"page":"60-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Higher T-SPOT.TB threshold may aid in diagnosing active tuberculosis?: A real-world clinical practice in a general hospital"],"prefix":"10.1016","volume":"509","author":[{"given":"Qingluan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chubin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoling","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haocheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyun","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2020.06.005_b0005","series-title":"Global tuberculosis report","author":"Organization","year":"2019"},{"key":"10.1016\/j.cca.2020.06.005_b0010","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S1473-3099(13)70034-3","article-title":"Tuberculosis biomarkers discovery: developments, needs, and challenges","volume":"13","author":"Wallis","year":"2013","journal-title":"Lancet. Infect. Dis"},{"key":"10.1016\/j.cca.2020.06.005_b0015","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S1473-3099(17)30691-6","article-title":"Xpert MTB\/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study","volume":"18","author":"Dorman","year":"2018","journal-title":"Lancet. Infect. Dis"},{"key":"10.1016\/j.cca.2020.06.005_b0020","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0140-6736(00)02742-2","article-title":"Specific immune-based diagnosis of tuberculosis","volume":"356","author":"Andersen","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2020.06.005_b0025","doi-asserted-by":"crossref","first-page":"177","DOI":"10.7326\/0003-4819-149-3-200808050-00241","article-title":"Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update","volume":"149","author":"Pai","year":"2008","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.cca.2020.06.005_b0030","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ijid.2019.11.023","article-title":"Preventive tuberculosis treatment effect on QuantiFERON TB-Gold in-tube testing in a high tuberculosis-endemic country: A clinical trial","volume":"91","author":"Yang","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.cca.2020.06.005_b0035","doi-asserted-by":"crossref","first-page":"989","DOI":"10.5588\/ijtld.18.0252","article-title":"Serial T-SPOT.TB in household contacts of tuberculosis patients: a 6-year observational study in China","volume":"23","author":"Zhang","year":"2019","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"10.1016\/j.cca.2020.06.005_b0040","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1186\/s12879-019-4597-8","article-title":"Clinical effect of T-SPOT.TB test for the diagnosis of tuberculosis","volume":"19","author":"Ma","year":"2019","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.cca.2020.06.005_b0045","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1183\/09031936.00114810","article-title":"Interferon-gamma release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis","volume":"37","author":"Sester","year":"2011","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.cca.2020.06.005_b0050","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3389\/fcimb.2017.00457","article-title":"Application of ImmunoScore Model for the Differentiation between Active Tuberculosis and Latent Tuberculosis Infection as Well as Monitoring Anti-tuberculosis Therapy","volume":"7","author":"Zhou","year":"2017","journal-title":"Front. Cell Infect. Microbiol."},{"key":"10.1016\/j.cca.2020.06.005_b0055","doi-asserted-by":"crossref","first-page":"487","DOI":"10.5588\/ijtld.15.0756","article-title":"Using the TBAg\/PHA ratio in the T-SPOT((R)).TB assay to distinguish TB disease from LTBI in an endemic area","volume":"20","author":"Wang","year":"2016","journal-title":"Int. J. Tuberc. Lung. Dis."},{"key":"10.1016\/j.cca.2020.06.005_b0060","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1183\/09031936.00028507","article-title":"Quantitative scoring of an interferon-gamma assay for differentiating active from latent tuberculosis","volume":"30","author":"Janssens","year":"2007","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.cca.2020.06.005_b0065","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.cca.2018.01.014","article-title":"Evaluation of the performance of two tuberculosis interferon gamma release assays (IGRA-ELISA and T-SPOT. TB) for diagnosing Mycobacterium tuberculosis infection","volume":"479","author":"Wang","year":"2018","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2020.06.005_b0070","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1128\/CMR.00034-13","article-title":"Gamma Interferon Release Assays for Detection of Mycobacterium tuberculosis Infection","volume":"27","author":"Pai","year":"2014","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.cca.2020.06.005_b0075","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1136\/thoraxjnl-2012-203086","article-title":"Incremental value of T-SPOT.TB for diagnosis of active pulmonary tuberculosis in children in a high-burden setting: a multivariable analysis","volume":"68","author":"Ling","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.cca.2020.06.005_b0080","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1164\/rccm.201208-1352OC","article-title":"Interferon-gamma ELISPOT as a biomarker of treatment efficacy in latent tuberculosis infection: a clinical trial","volume":"187","author":"Adetifa","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.cca.2020.06.005_b0085","doi-asserted-by":"crossref","first-page":"5217","DOI":"10.4049\/jimmunol.167.9.5217","article-title":"Direct Ex Vivo Analysis of Antigen-Specific IFN- -Secreting CD4 T Cells in Mycobacterium tuberculosis-Infected Individuals: Associations with Clinical Disease State and Effect of Treatment","volume":"167","author":"Pathan","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.cca.2020.06.005_b0090","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1164\/rccm.200608-1109OC","article-title":"Latent tuberculosis infection treatment and T-cell responses to Mycobacterium tuberculosis-specific antigens","volume":"175","author":"Chee","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.cca.2020.06.005_b0095","first-page":"713","article-title":"The performance and limitation of T-SPOT.TB for the diagnosis of TB in a high prevalence setting","volume":"6","author":"Zhu","year":"2014","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.cca.2020.06.005_b0100","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1177\/0300060518757381","article-title":"Evaluation of risk factors for false-negative results with an antigen-specific peripheral blood-based quantitative T cell assay (T-SPOT((R)). TB) in the diagnosis of active tuberculosis: A large-scale retrospective study in China","volume":"46","author":"Yang","year":"2018","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.cca.2020.06.005_b0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078924","article-title":"Type 2 diabetes: an independent risk factor for tuberculosis: a nationwide population-based study","volume":"8","author":"Kuo","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cca.2020.06.005_b0110","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3109\/00365548.2014.885657","article-title":"Diabetes is associated with lower tuberculosis antigen-specific interferon gamma release in Tanzanian tuberculosis patients and non-tuberculosis controls","volume":"46","author":"Faurholt-Jepsen","year":"2014","journal-title":"Scand J. Infect. Dis."},{"key":"10.1016\/j.cca.2020.06.005_b0115","series-title":"Latent tuberculosis infection: updated and consolidated guidelines for programmatic management","author":"Organization","year":"2018"},{"key":"10.1016\/j.cca.2020.06.005_b0120","doi-asserted-by":"crossref","first-page":"e00629","DOI":"10.1128\/JCM.00629-18","article-title":"Specificity of QuantiFERON-TB Plus, a New-Generation Interferon Gamma Release Assay","volume":"56","author":"Siegel","year":"2018","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.cca.2020.06.005_b0125","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.advms.2019.09.001","article-title":"Comparison of the QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube interferon-\u03b3 release assays: A systematic review and meta-analysis","volume":"64","author":"Pourakbari","year":"2019","journal-title":"Adv. Med. Sci."},{"key":"10.1016\/j.cca.2020.06.005_b0130","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jinf.2019.08.018","article-title":"QuantiFERON TB Gold Plus for the diagnosis of tuberculosis: a systematic review and meta-analysis","volume":"79","author":"Sotgiu","year":"2019","journal-title":"J. Infect."},{"key":"10.1016\/j.cca.2020.06.005_b0135","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S1473-3099(18)30613-3","article-title":"Clinical utility of existing and second-generation interferon-\u03b3 release assays for diagnostic evaluation of tuberculosis: an observational cohort study","volume":"19","author":"Whitworth","year":"2019","journal-title":"Lancet. Infect. Dis."},{"key":"10.1016\/j.cca.2020.06.005_b0140","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1093\/cid\/ciu022","article-title":"Xpert MTB\/RIF testing in a low tuberculosis incidence, high-resource setting: limitations in accuracy and clinical impact","volume":"58","author":"Sohn","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.cca.2020.06.005_b0145","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/ibd.21427","article-title":"Factors impacting the results of interferon-gamma release assay and tuberculin skin test in routine screening for latent tuberculosis in patients with inflammatory bowel diseases","volume":"17","author":"Papay","year":"2011","journal-title":"Inflamm. Bowel. Dis."},{"key":"10.1016\/j.cca.2020.06.005_b0150","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/01.MIB.0000438429.38423.62","article-title":"T-Cell Profiling and the Immunodiagnosis of Latent Tuberculosis Infection in Patients with Inflammatory Bowel Disease","volume":"20","author":"Arias-Guill\u00e9n","year":"2014","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.cca.2020.06.005_b0155","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1136\/annrheumdis-2011-200941","article-title":"Screening for latent tuberculosis infection: performance of tuberculin skin test and interferon-\u03b3 release assays under real-life conditions","volume":"71","author":"Kleinert","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cca.2020.06.005_b0160","doi-asserted-by":"crossref","first-page":"412","DOI":"10.5588\/ijtld.16.0428","article-title":"Novel interferon-gamma assays for diagnosing tuberculosis in young children in India","volume":"21","author":"Shaikh","year":"2017","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"10.1016\/j.cca.2020.06.005_b0165","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3389\/fped.2019.00208","article-title":"Risk Factors for Indeterminate Interferon-Gamma Release Assay for the Diagnosis of Tuberculosis in Children-A Systematic Review and Meta-Analysis","volume":"7","author":"Meier","year":"2019","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.cca.2020.06.005_b0170","doi-asserted-by":"crossref","first-page":"534","DOI":"10.3201\/eid2403.171633","article-title":"Characteristics Associated with Negative Interferon-\u03b3 Release Assay Results in Culture-Confirmed Tuberculosis Patients, Texas, USA, 2013\u20132015","volume":"24","author":"Nguyen","year":"2018","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.cca.2020.06.005_b0175","doi-asserted-by":"crossref","first-page":"773","DOI":"10.7754\/Clin.Lab.2016.161007","article-title":"Factors contributing to false-negative enzyme-linked immunospot assay for interferon-gamma results in active tuberculosis","volume":"63","author":"Lian","year":"2017","journal-title":"Clin. Lab."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898120302692?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898120302692?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:53:34Z","timestamp":1757861614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898120302692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":35,"alternative-id":["S0009898120302692"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2020.06.005","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Higher T-SPOT.TB threshold may aid in diagnosing active tuberculosis?: A real-world clinical practice in a general hospital","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2020.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}